Heart disease has held the title of the world’s leading cause of death for over a century. Unfortunately, the future does not seem to offer any relief from this statistic.

As the demand for weight loss medications surges, the availability of Zepbound, manufactured by Eli Lilly, faces significant shortages, with no immediate solution in sight. The FDA approved Zepbound in November, offering a new option for weight loss alongside Novo Nordisk’s Wegovy. However, despite earlier assurances from Lilly’s CEO, Dave Ricks, shortages have become widespread […]

New research sheds light on the effectiveness of gastric bypass surgery in maintaining remission of type 2 diabetes, even if patients regain weight over time. Dr. Alexander Abkin, a leading bariatric surgeon in New Jersey, helps break down the findings for us.

A recent study published in the Journal of the American College of Cardiology found that people who have obesity often struggle with high blood pressure. However, those who undergo weight loss surgery, called bariatric surgery, tend to have better results in lowering their blood pressure compared to those who only rely on medication.”

In recent years, the rising popularity of semaglutide has become a cause for concern, with poison control centers reporting a staggering increase in calls related to this drug. The surge, amounting to over 1,500% since 2019, has predominantly been attributed to dosage errors, leading to a nightmare scenario for both patients and healthcare providers.